Document is current
Any future updates will be listed below
-
Authors
Sharma, Hari A. https://orcid.org/0000-0002-8641-1702
McAlindon, Timothy E.
Roberts, Mary B.
Haugen, Ida K.
Lo, Grace H.
Duryea, Jeffrey
Schaefer, Lena F.
Smith, Stacy E.
Eaton, Charles B.
Driban, Jeffrey B. https://orcid.org/0000-0001-6098-4273
-
Funding
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR066378)
National Institutes of Health (N01-AR-2-2258, N01-AR-2-2259, N01-AR-2-2260, N01-AR-2-2261, N01-AR-2-2262)
- License Information
-
More Information
Article History
Received: 14 April 2024
Revised: 12 August 2024
Accepted: 13 August 2024
First Online: 22 August 2024
Declarations
:
: Dr. McAlindon reports grants from NIAMS, during the conduct of the study. Dr. McAlindon also reports personal fees from Organogenesis, Medipost, Scarcell, Grunenthal, Sanofi, and Kolon TissueGene, Inc., outside the submitted work. Dr. Haugen reports personal fees from AbbVie, grants from Pfizer, outside the submitted work. Dr. Driban reports personal fees from Pfizer and Eli Lilly, outside the submitted work. The other authors declare no conflicts of interest.
